Bayer is facing demands from activist investor Bluebell Capital Partners to break up, a person familiar with the matter told Reuters, pushing shares in the diversified health and agriculture group to a five-week high.
Bluebell did not immediately respond to a request for comment. The size of Bluebell's holding was not immediately clear. A Bayer spokesperson said the company was open in general for constructive dialogue with stakeholders and declined to comment further.Voyager gets initial approval for $1N Binance deal amid national security concerns
U.S. Bankruptcy Judge Michael Wiles in New York allowed Voyager to enter into an asset purchase agreement with Binance.US and to solicit creditor votes on the sale, which will not become final until a future court hearing.